Clinical Trials Directory

Trials / Completed

CompletedNCT07496047

Clinical Evaluation of Short Fiber-Reinforced Composite Restorations With and Without Preheating Approach

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
25 Years – 40 Years
Healthy volunteers
Accepted

Summary

To clinically evaluate the performance of preheated versus non-preheated short fiber-reinforced composite (SFRC) restorations in Class I posterior cavities over a 12-month period

Detailed description

Resin-based composites are widely used for posterior restorations due to their aesthetic properties and adhesive capabilities. However, polymerization shrinkage stress and insufficient fracture resistance remain major concerns in stress-bearing areas. Short fiber-reinforced composites (SFRCs) were developed to improve mechanical properties and crack-stopping ability. everX Posterior (GC Corporation, Tokyo, Japan) contains randomly oriented E-glass fibers within a resin matrix, enhancing fracture toughness and load-bearing capacity. Preheating composite materials has been proposed to reduce viscosity, improve flow, enhance cavity adaptation, and potentially increase the degree of conversion. Elevated temperature reduces internal friction among monomers, thereby improving polymerization kinetics. Despite promising laboratory findings, limited clinical evidence exists regarding the impact of preheating on SFRC performance. Therefore, this randomized clinical trial aimed to evaluate the clinical behavior of SFRC restorations placed with and without preheating in Class I cavities over 12 months

Conditions

Interventions

TypeNameDescription
OTHERPreheated everX Posterior compositeApplication of everX Posterior composite after preheating to 54°C using a composite warmer, followed by placement, adaptation, and curing according to manufacturer guidelines.
OTHERNon-preheated everX Posterior compositeApplication of everX Posterior composite at room temperature, placed and cured according to manufacturer instructions.

Timeline

Start date
2025-03-01
Primary completion
2026-03-17
Completion
2026-03-20
First posted
2026-03-27
Last updated
2026-03-27

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07496047. Inclusion in this directory is not an endorsement.